Your browser doesn't support javascript.
loading
Oral fibrinogen-depleting agent lumbrokinase for secondary ischemic stroke prevention: results from a multicenter, randomized, parallel-group and controlled clinical trial.
Cao, Yong-Jun; Zhang, Xia; Wang, Wan-Hua; Zhai, Wan-Qing; Qian, Ju-Fen; Wang, Jian-Sheng; Chen, Jun; You, Nian-Xing; Zhao, Zhong; Wu, Qiu-Yi; Xu, Yuan; Yuan, Lei; Li, Rui-Xia; Liu, Chun-Feng.
Affiliation
  • Cao YJ; Department of Neurology, Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, China.
Chin Med J (Engl) ; 126(21): 4060-5, 2013 Nov.
Article in En | MEDLINE | ID: mdl-24229674
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Endopeptidases / Fibrinogen / Stroke Type of study: Clinical_trials / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Chin Med J (Engl) Year: 2013 Document type: Article Affiliation country:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Endopeptidases / Fibrinogen / Stroke Type of study: Clinical_trials / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Chin Med J (Engl) Year: 2013 Document type: Article Affiliation country: